BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3839406)

  • 1. Histogenesis of hyperosteoidosis in 1,25(OH)2D3-treated rats fed high levels of dietary calcium.
    Boyce RW; Weisbrode SE
    Bone; 1985; 6(2):105-12. PubMed ID: 3839406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
    Boyce RW; Weisbrode SE
    Lab Invest; 1983 Jun; 48(6):683-9. PubMed ID: 6687909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural development of hyperosteoidosis in 1,25(OH)2D3-treated rats fed high levels of dietary calcium.
    Boyce RW; Weisbrode SE; Kindig O
    Bone; 1985; 6(3):165-72. PubMed ID: 3839678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3.
    Lindgren JU; Johnell O; DeLuca HF
    Clin Orthop Relat Res; 1983 Dec; (181):264-8. PubMed ID: 6688979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF; Hermey DC; Popoff SN; Seifert MF
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats fed a low-calcium diet.
    Weisbrode SE; Capen CC; Norman AW
    Am J Pathol; 1978 Aug; 92(2):459-72. PubMed ID: 677270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of renal production of 24,25- and 1,25-dihydroxyvitamin D3 in young and adult rats by dietary calcium, phosphorus, and 1,25-dihydroxyvitamin D3.
    Armbrecht HJ; Zenser TV; Davis BB
    Endocrinology; 1982 Jun; 110(6):1983-8. PubMed ID: 6978809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light- and electron-microscopic evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats.
    Weisbrode SE; Capen CC; Norman AW
    Am J Pathol; 1979 Nov; 97(2):247-60. PubMed ID: 525673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M; Hock JM; Gera I; Fonseca J; Poser J; Bevan J; Raisz LG
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
    Marie PJ; Hott M; Garba MT
    Calcif Tissue Int; 1985 May; 37(3):268-75. PubMed ID: 3926276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.
    Goodman WG; Baylink DJ; Sherrard DJ
    Calcif Tissue Int; 1984 Mar; 36(2):206-13. PubMed ID: 6430503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the major vitamin D metabolites upon the resolution of osteomalacia in uremic adult rats.
    Lieuallen WG; Weisbrode SE; Horst RL
    Bone; 1990; 11(4):267-73. PubMed ID: 2242292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.
    Marie PJ; Travers R
    Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-Dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats.
    Burnatowska-Hledin MA; Doyle TM; Eadie MJ; Mayor GH
    J Lab Clin Med; 1986 Aug; 108(2):96-102. PubMed ID: 3755457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
    Gallagher JA; Beneton M; Harvey L; Lawson DE
    Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 1,25-dihydroxicolecalciferol and dietary calcium-phosphate on distribution of lead to tissues during growth.
    Cortina-Ramírez GE; Cerbón-Solorzano J; Calderón-Salinas JV
    Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):123-7. PubMed ID: 16223518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse.
    Marie PJ; Hott M; Garba MT
    Metabolism; 1985 Aug; 34(8):777-83. PubMed ID: 3839559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clomiphene and tamoxifen in vivo on the bone-resorbing effects of parathyroid hormone and of high oral doses of calcitriol (1,25(OH)2D3) in rats with intact ovarian function consuming low calcium diet.
    Goulding A; Gold E; Fisher L
    Bone Miner; 1990 Mar; 8(3):185-93. PubMed ID: 2322693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of 1,25-dihydroxycholecalciferol, parathyroid hormone, and thyroxine on trabecular bone remodeling in adult dogs. A histomorphometric study.
    High WB; Capen CC; Black HE
    Am J Pathol; 1981 Dec; 105(3):279-87. PubMed ID: 6895577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of local application of 1,25 (OH)2D3 on experimental tooth movement in rats].
    Kawakami M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):128-46. PubMed ID: 2135402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.